Analyst Research

Report Title Price
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cardiome Pharma Corp Announces Changes To Senior Management Team


Tuesday, 26 Mar 2013 07:24pm EDT 

Cardiome Pharma Corp announced changes to the Company's senior management team. William Hunter, M.D., previously interim Chief Executive Officer (CEO) and Director, has been appointed full time President and CEO. 

Latest Key Developments in Pharmaceuticals

Company Quote

7.32
-0.21 -2.79%
11 Jul 2014